Hellow guys, Welcome to my website, and you are watching “The Buzz'' Show: Voyager Therapeutics, Inc. (NASDAQ: VYGR) License Option Deal with Pfizer. and this vIdeo is uploaded by FinancialBuzzMedia at 2021-10-06T14:06:24-07:00. We are pramote this video only for entertainment and educational perpose only. So, I hop you like our website.
| Name | “The Buzz'' Show: Voyager Therapeutics, Inc. (NASDAQ: VYGR) License Option Deal with Pfizer |
| Video Uploader | Video From FinancialBuzzMedia |
| Upload Date | This Video Uploaded At 06-10-2021 21:06:24 |
| Video Discription | FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Voyager Therapeutics, Inc. on the Rise after announcing license option deal with Pfizer” “The Buzz'' Show: Voyager Therapeutics, Inc. on the Rise after announcing license option deal with Pfizer Voyager Therapeutics, Inc. (NASDAQ: VYGR) surged over 61% in premarket trading after the company announced a license option agreement with Pfizer for next-generation TRACERᵀᴹ AAV Capsids. Through the agreement, Pfizer Inc may exercise options to license novel capsids generated from Voyager’s RNA-driven TRACER screening technology and Voyager receives $30 million up front with potential option exercise fees and milestone payments of up to $600 million plus product sales-based royalties. Voyager Therapeutics (Nasdaq: VYGR) is leading the next generation of AAV gene therapy to unlock the potential of the technology to treat devastating diseases. Proprietary capsids born from the Company’s TRACER screening platform are powering a rich early-stage pipeline of new and second-generation programs and may elevate the field to overcome the limitations of conventional gene therapy vectors across neurologic disorders and other therapeutic areas. For more "The Buzz" please visit: https://bit.ly/2Rlh4zH About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. © 2011 Financial Buzz. All rights reserved. No portion of this video or FinancialBuzz.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. FinancialBuzz.com has not been compensated directly by any of the companies mentioned here in this editorial unless mentioned otherwise. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. |
| Category | News & Politics |
| Tags | Financial News | Business News | Finance | Stock Market News | Investment News | OptionAgreement | Pfizer | Capsids | License | Royalties | Deal | RNA | Treatment | Pharmaceutical |
